Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease

Abstract Cure rates for pulmonary disease caused by the Mycobacterium avium complex (MAC) are poor. While β-lactam are front line antibiotics against Mycobacterium abscessus pulmonary disease, they have not been used or recommended to treat MAC lung infections. Through a comprehensive screen of oral...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infectious diseases 2024-08, Vol.230 (2), p.e241-e246
Hauptverfasser:	Negatu, Dereje A, Shin, Sung Jae, Kim, Su-Young, Jhun, Byung Woo, Dartois, Véronique, Dick, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Amoxicillin Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Antibiotics beta-Lactams - administration & dosage beta-Lactams - therapeutic use Brief Report Bronchopulmonary infection Carbapenems Cefuroxime Clinical trials Humans Lung diseases Lung Diseases - drug therapy Lung Diseases - microbiology Microbial Sensitivity Tests Mycobacterium avium Mycobacterium avium Complex - drug effects Mycobacterium avium-intracellulare Infection - drug therapy Mycobacterium avium-intracellulare Infection - microbiology Penicillin β-Lactam antibiotics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!